among mds patients , those with primary acquired sideroblastic ( aisa ) and refractory ( ra ) anemia had median survival similar to those with maa , but distinctly longer ( p = 0.01 ) than patients with ra with an excess of blasts ( raeb ) , raeb in transformation ( raebtr ) and chronic myelomonocytic leukemia ( cmmol ) .
C0002893
refractory
C0002894
raeb